Howmet Aerospace R&D decreased by 10.0% to $9.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.5%, from $8.00M to $9.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 21.5% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $4.00M | $4.00M | $7.00M | $9.00M | $7.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $10.00M | $7.00M | $9.00M | $7.00M | $8.00M | $9.00M | $10.00M | $10.00M | $9.00M |
| QoQ Change | — | +0.0% | +0.0% | +75.0% | +28.6% | -22.2% | +28.6% | +0.0% | +0.0% | +0.0% | +0.0% | +11.1% | -30.0% | +28.6% | -22.2% | +14.3% | +12.5% | +11.1% | +0.0% | -10.0% |
| YoY Change | — | — | — | — | +125.0% | +75.0% | +125.0% | +28.6% | +0.0% | +28.6% | +0.0% | +11.1% | -22.2% | +0.0% | -22.2% | -20.0% | +28.6% | +11.1% | +42.9% | +12.5% |